GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Small and Large Bowel/Diverticulitis

Diverticulitis

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated November 1, 2025

Quick Answer

Diverticulitis is a medical condition characterized by the inflammation or infection of small, bulging pouches (diverticula) that can form in the lining of the digestive system, most commonly in the colon. It is a more serious condition compared to diverticulosis, which refers to the presence of these pouches without inflammation or symptoms.


Diverticulitis is a medical condition characterized by the inflammation or infection of small, bulging pouches (diverticula) that can form in the lining of the digestive system, most commonly in the colon. It is a more serious condition compared to diverticulosis, which refers to the presence of these pouches without inflammation or symptoms. Below is a comprehensive explanation of diverticulitis, derived from the provided context:

---

### **Definition and Overview**

  • **Diverticulosis**: The condition where multiple small pouches (diverticula) form in the lining of the intestine, typically in the colon. It is often asymptomatic.
  • **Diverticulitis**: The inflammation or infection of these diverticula, which can cause significant symptoms and complications.

---

### **Prevalence**

  • **Annual Incidence**: In the U.S., the annual incidence of diverticulitis is approximately 180 cases per 100,000 people.
  • **Healthcare Impact**: Diverticulitis accounts for around 200,000 hospitalizations yearly in the U.S., with an estimated financial burden of $6.3 billion in healthcare costs.

---

### **Risk Factors**

1. **Age**: More common in individuals over 65 years old.

2. **Genetics**: Variants in the *TNFSF15* gene are associated with increased risk.

3. **Connective Tissue Disorders**: Conditions like Marfan syndrome and Ehlers-Danlos syndrome increase susceptibility.

4. **Obesity**: A body mass index (BMI) of 30 or higher is a significant risk factor.

5. **Medications**: Use of opioids, steroids, and nonsteroidal anti-inflammatory drugs (NSAIDs).

6. **Chronic Diseases**: Hypertension and type 2 diabetes are associated with a higher risk.

---

### **Progression from Diverticulosis to Diverticulitis**

  • Only **1–4%** of individuals with diverticulosis develop acute diverticulitis in their lifetime.
  • **Symptoms of Diverticulitis**:
  • Left lower quadrant abdominal pain
  • Fever
  • Nausea and vomiting
  • Leukocytosis (elevated white blood cell count)

---

### **Diagnosis**

  • **Preferred Diagnostic Tool**: A contrast-enhanced abdominal and pelvic CT scan is the gold standard for diagnosing diverticulitis.
  • Sensitivity: 98–99%
  • Specificity: 99–100%

---

### **Types of Diverticulitis**

1. **Uncomplicated Diverticulitis**:

  • Accounts for approximately **85% of cases**.
  • Defined by the absence of complications such as abscess, perforation, fistula, or obstruction.

2. **Complicated Diverticulitis**:

  • Involves complications like abscess formation, perforation, fistulas, or intestinal obstruction.
  • Requires more intensive treatment, including possible surgical intervention.

---

### **Management of Uncomplicated Diverticulitis**

1. **Initial Treatment**:

  • Observation and monitoring.
  • Pain control using **acetaminophen**.
  • A **clear liquid diet** to allow the bowel to rest.

2. **Antibiotic Use**:

  • Antibiotics are not routinely required unless systemic symptoms develop.
  • Criteria for antibiotic use include:
  • Fever and chills
  • Elevated white blood cell count
  • Age over 80 years
  • Pregnancy
  • Immunocompromised state
  • Chronic diseases such as chronic kidney disease (CKD), cirrhosis, or heart failure.

3. **Oral Antibiotic Regimens**:

  • **Amoxicillin/clavulanic acid**.
  • **Cefalexin** plus **metronidazole**.

4. **Intravenous (IV) Antibiotic Regimens** (if oral intake is not possible):

  • **Cefuroxime** or **ceftriaxone** plus **metronidazole**.
  • **Ampicillin/sulbactam**.

---

### **Management of Complicated Diverticulitis**

1. **IV Antibiotics**:

  • **Ceftriaxone** plus **metronidazole**.
  • **Piperacillin-tazobactam**.

2. **Procedures**:

  • **Percutaneous Abscess Drainage**: For localized abscesses.
  • **Colon Resection Surgery**:
  • **Elective Surgery**: Performed in stable patients.
  • **Emergent Surgery**: Required for severe cases with generalized peritonitis.

---

### **Surgical Intervention and Mortality**

  • **Emergent Surgery**: Laparotomy with colonic resection is indicated for generalized peritonitis.
  • Postoperative mortality is **10.6%** for emergent surgeries.
  • **Elective Surgery**: Associated with a much lower postoperative mortality rate of **0.5%**.

---

### **Key Takeaways (20 Points)**

1. Diverticulosis is the presence of small pouches in the colon, while diverticulitis is their inflammation or infection.

2. Diverticulitis affects around 180 per 100,000 people annually in the U.S.

3. Diverticulitis leads to approximately 200,000 hospitalizations and $6.3 billion in healthcare costs each year.

4. Only 1–4% of people with diverticulosis progress to diverticulitis in their lifetime.

5. Risk increases with age, especially in those over 65 years.

6. Genetic factors, particularly the *TNFSF15* gene, may predispose individuals to diverticulitis.

7. Connective tissue disorders, such as Marfan syndrome and Ehlers-Danlos syndrome, increase risk.

8. Obesity (BMI ≥30) is a significant risk factor.

9. Medications like opioids, steroids, and NSAIDs are associated with a higher risk.

10. Chronic conditions like hypertension and type 2 diabetes increase susceptibility.

11. Symptoms of diverticulitis include left lower quadrant pain, fever, nausea, vomiting, and elevated WBC.

12. A contrast-enhanced CT scan is the preferred diagnostic tool, with near-perfect sensitivity and specificity.

13. 85% of diverticulitis cases are uncomplicated, meaning they lack severe complications.

14. Uncomplicated diverticulitis is managed with observation, pain control, and a clear liquid diet.

15. Antibiotics are not routinely required for uncomplicated cases unless systemic symptoms are present.

16. Antibiotics are indicated for patients with fever, elevated WBC, advanced age, pregnancy, immunosuppression, or chronic diseases.

17. Oral antibiotics include amoxicillin/clavulanic acid or cefalexin plus metronidazole.

18. IV antibiotics include cefuroxime or ceftriaxone plus metronidazole, or ampicillin/sulbactam.

19. Complicated diverticulitis may require IV antibiotics, percutaneous abscess drainage, or colon resection surgery.

20. Postoperative mortality is 0.5% for elective surgeries and 10.6% for emergent surgeries.

---

### **Conclusion**

Diverticulitis is a potentially serious condition that requires prompt diagnosis and appropriate management. While most cases are uncomplicated and can be managed conservatively, complicated cases may require surgical intervention. Early recognition of symptoms and risk factors is crucial to prevent progression and complications.

Related Q&A

Anal High-Grade Squamous Intraepithelial Lesions (HSIL): BJS | March 2026

Introduction: Anal squamous cell carcinoma is an increasingly common but largely preventable cancer. Most cases arise from persistent high-risk human papillomavirus (HPV) infection, progressing through high-grade squamous intraepithelial lesions (HSIL). This comprehensive review summarizes the...

Post-Infection DGBI (PI-DGBI): Gut | July 2026

Introduction: Acute infectious gastroenteritis can trigger persistent gastrointestinal symptoms long after the infection has resolved, leading to post-infection disorders of gut-brain interaction (PI-DGBI). This global Rome Foundation study evaluated the prevalence, risk factors, and clinical...

FMT in IBS: Gastroenterology | July 2026

Introduction: Gut microbiota alterations have been implicated in the pathogenesis of irritable bowel syndrome (IBS), making fecal microbiota transplantation (FMT) a promising therapeutic strategy. However, clinical trials have reported conflicting results. This updated meta-analysis evaluated...

Laparoscopic vs Open Adhesiolysis for Bowel Obstruction: JAMA Surgery | June 2026

Introduction: Laparoscopic adhesiolysis offers several short-term advantages over open surgery for adhesive small bowel obstruction (ASBO). However, its long-term impact on recurrence, quality of life, and incisional hernia remains uncertain. The LASSO trial provides the...

DPP-4 Inhibition Targets the Gut–Brain Axis in Parkinson's Disease: Gut | July 2026

Introduction: Growing evidence suggests that Parkinson's disease (PD) may originate in the gut, with pathological α-synuclein spreading to the brain through the vagus nerve. This study investigated whether sitagliptin, a widely used DPP-4 inhibitor for...

Bedside Ultrasound Outperforms Abdominal X-Ray in Neonatal Necrotizing Enterocolitis: Frontiers in Pediatrics | July 2026

Introduction: Necrotizing enterocolitis (NEC) is one of the most serious gastrointestinal emergencies in neonates. Early identification of infants requiring surgical intervention is critical but remains challenging. This study compared bedside abdominal ultrasonography (US) with abdominal...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer